CFCThe Compounder Score

Financial statements are reported in CAD. Prices converted from USD at today's exchange rate. Tranches and alerts stay in USD.

Show values in
ACB logo

ACB — Aurora Cannabis Inc.

Drug Manufacturers - Specialty & GenericHealthcare

CA$ 7.05

CA$ -0.07 (-1.00%)

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.

Market Cap

CA$ 463.43M

Forward P/E

-44.9x

52-Week Range

N/A

ACB Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

CA$ 321M

Revenue · FY2026

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

-CA$ 36.1M

FCF · FY2026

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

-10.2%

ROCE · FY2026

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

6.7x

Assets ÷ liabilities · FY2026

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

7.0%

CapEx · FY2026

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+3.4%

Dilution · FY2026

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).